Dewelt Pharma Private Limited

Dewelt Pharma Private Limited - chemicals in Haridwar, Uttarakhand, India. FY 2026 financials & compliance.
CIN U74220UR2013PTC000804 Incorporated 23 July 2013 ROC Uttarakhand HQ Haridwar, Uttarakhand, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2017
₹3.92 Lakh
Latest filing
Net profit · FY 2017
₹22,493
Net margin 5.7%
EBITDA · FY 2017
₹45,693
EBITDA margin 11.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Dewelt Pharma Private Limited

Data last updated:

Dewelt Pharma Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 23 July 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74220UR2013PTC000804. Its GSTIN is 05AATCS6563N1ZG (Uttarakhand).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Solvay Lab (India) Private Limited. It is led by directors Sunil Kumar and Vinod.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at J.P. Pokhiriyal S/O Sh. Kanhiya Lal C/O Village Rasoolpur Mithiberi, Haridwar, Uttarakhand, India – 249404.

As per the financials filed for FY 2017, the company reported a revenue of ₹3.92 Lakh. For the same year it recorded a net profit of ₹22,493 (net margin 5.7%) and EBITDA of ₹45,693 (EBITDA margin 11.7%).

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74220UR2013PTC000804
Registration Number 000804
Incorporation Date 23 July 2013
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Dewelt Pharma Private Limited's registered office is in Haridwar, Uttarakhand. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    J.P. Pokhiriyal S/O Sh. Kanhiya Lal C/O Village Rasoolpur Mithiberi, Haridwar, Uttarakhand, India – 249404
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products

To see the full contact details of Dewelt Pharma Private Limited, buy the company report.

Comprehensive company report
Dewelt Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Dewelt Pharma Private Limited

FY 2025 filings available

Dewelt Pharma Private Limited reported revenue of ₹3.92 Lakh for FY 2017.

Revenue · FY 2017
₹3.92 Lakh
Net profit · FY 2017
₹22,493 margin 5.7%
EBITDA · FY 2017
₹45,693 margin 11.7%

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹3.92 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹45,693
Profit Before Tax
Tax Expense
Net Profit (PAT)₹22,493
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin11.7%
Net Profit Margin5.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dewelt Pharma Private Limited, buy the company report.

Board of directors of Dewelt Pharma Private Limited

Dewelt Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunil KumarDirector04 Oct 20179 Years 0 MonthsCurrent
VinodDirector23 Jul 201313 Years 3 MonthsCurrent

Auditor

Dewelt Pharma Private Limited is audited by ANSHUL S AGARWAL & CO. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
ANSHUL S AGARWAL & CO.FY 2017421043

Shareholding

The shareholding of Dewelt Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dewelt Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dewelt Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Dewelt Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
05AATCS6563N1ZGUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Dewelt Pharma Private Limited, buy the company report.

Recent activity

Dewelt Pharma Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Neelam Pokhriyal ceased to be Director on 04 Oct 2017.

AGM
Dewelt Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dewelt Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Ceased
Neelam Pokhriyal ceased to be Director.
Appointed
Sunil Kumar was appointed as Director.
Appointed
Neelam Pokhriyal was appointed as Director.
Appointed
Vinod was appointed as Director.
Incorporation
23 Jul 2013
Dewelt Pharma Private Limited was registered on 23 Jul 2013 with Roc Uttarakhand & aged 13 years 3 months as per MCA records.

Frequently asked questions

Dewelt Pharma is an active private limited company based in Haridwar, Uttarakhand, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 23 July 2013 (13+ years old) and is registered under CIN U74220UR2013PTC000804.

Dewelt Pharma has 2 current directors:

The latest financial statements of Dewelt Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Dewelt Pharma is 05AATCS6563N1ZG, registered in Uttarakhand.

The CIN (Corporate Identification Number) of Dewelt Pharma is U74220UR2013PTC000804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dewelt Pharma was incorporated on 23 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttarakhand.

Neelam Pokhriyal ceased to be Director on 04 Oct 2017. Sunil Kumar was appointed as Director on 04 Oct 2017. Neelam Pokhriyal was appointed as Director on 23 Jul 2013. Dewelt Pharma has 4 board changes on record in total.

The registered office of Dewelt Pharma is at J.P. Pokhiriyal SO Sh. Kanhiya Lal CO Village Rasoolpur Mithiberi, Haridwar, Uttarakhand, India – 249404.

Dewelt Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.

The compliance status of Dewelt Pharma is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.